{"id":946156,"date":"2026-03-23T08:20:30","date_gmt":"2026-03-23T12:20:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/"},"modified":"2026-03-23T08:20:30","modified_gmt":"2026-03-23T12:20:30","slug":"mimedx-announces-launch-of-choriofix","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/","title":{"rendered":"MIMEDX Announces Launch of CHORIOFIX\u2122"},"content":{"rendered":"

\nFurther Expands Company\u2019s Broad Portfolio of Advanced Wound Care (\u201cAWC\u201d) Products
\n<\/h2>\n
\n

MARIETTA, Ga., March 23, 2026 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMIMEDX\u201d or the \u201cCompany\u201d) today announced the commercial launch of CHORIOFIX\u2122, the latest advanced wound care innovation in its product portfolio of placental allografts.<\/p>\n

\u201cCHORIOFIX is an organically developed product, created based on our deep understanding of the scientific and clinical attributes of the chorion layer,\u201d stated Michelle Massee, MIMEDX VP, Research & Development. \u201cIt consists of two chorion layers with an intact intermediate layer, making it our thickest product to date. The allograft\u2019s structure enhances handling, particularly during positioning and suturing, while its uniform, dual-sided chorion configuration eliminates the need for orientation during application.\u201d<\/p>\n

\u201cI have used several MIMEDX products for complex lower extremity wound care in the hospital setting,\u201d added Andrew Horine, DO, Family Medicine Physician at Carroll County Memorial Hospital.\u00a0\u00a0 \u201cIn an early access evaluation of CHORIOFIX, I was impressed with the product\u2019s handling characteristics and the effective wound closure observed anecdotally in my patients. The naturally thicker composition is well-suited for use in large deficits and deep, tunneling wounds, which represent some of the most difficult wound types to treat effectively.\u201d<\/p>\n

Continuing its commitment to generate best-in-class scientific and clinical data, the Company has also added CHORIOFIX to its CAMPAIGN trial, a prospective randomized controlled trial (\u201cRCT\u201d) designed to evaluate the performance of EPIEFFECT and now CHORIOFIX against standard of care (\u201cSOC\u201d) in the treatment of non-healing diabetic foot ulcers (\u201cDFUs\u201d).\u00a0\u00a0<\/p>\n

CHORIOFIX is a lyophilized human placental allograft that includes two layers of chorion with attached intermediate layer. CHORIOFIX is intended for use as a barrier to provide a protective environment in acute and chronic wounds.<\/p>\n

\n About MIMEDX<\/strong>
\n
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company\u2019s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com<\/a>.<\/p>\n

\n Contact:<\/strong>
\n
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Further Expands Company\u2019s Broad Portfolio of Advanced Wound Care (\u201cAWC\u201d) Products MARIETTA, Ga., March 23, 2026 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMIMEDX\u201d or the \u201cCompany\u201d) today announced the commercial launch of CHORIOFIX\u2122, the latest advanced wound care innovation in its product portfolio of placental allografts. \u201cCHORIOFIX is an organically developed product, created based on our deep understanding of the scientific and clinical attributes of the chorion layer,\u201d stated Michelle Massee, MIMEDX VP, Research & Development. \u201cIt consists of two chorion layers with an intact intermediate layer, making it our thickest product to date. The allograft\u2019s structure enhances handling, particularly during positioning and suturing, while its uniform, dual-sided chorion configuration eliminates the need for orientation during application.\u201d \u201cI … <\/p>\n

Continue reading “MIMEDX Announces Launch of CHORIOFIX\u2122”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-946156","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMIMEDX Announces Launch of CHORIOFIX\u2122 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MIMEDX Announces Launch of CHORIOFIX\u2122 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Further Expands Company\u2019s Broad Portfolio of Advanced Wound Care (\u201cAWC\u201d) Products MARIETTA, Ga., March 23, 2026 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMIMEDX\u201d or the \u201cCompany\u201d) today announced the commercial launch of CHORIOFIX\u2122, the latest advanced wound care innovation in its product portfolio of placental allografts. \u201cCHORIOFIX is an organically developed product, created based on our deep understanding of the scientific and clinical attributes of the chorion layer,\u201d stated Michelle Massee, MIMEDX VP, Research & Development. \u201cIt consists of two chorion layers with an intact intermediate layer, making it our thickest product to date. The allograft\u2019s structure enhances handling, particularly during positioning and suturing, while its uniform, dual-sided chorion configuration eliminates the need for orientation during application.\u201d \u201cI … Continue reading "MIMEDX Announces Launch of CHORIOFIX\u2122"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-23T12:20:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NjI2NyM3NDk3MjA0IzIwMTA1Nzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MIMEDX Announces Launch of CHORIOFIX\u2122\",\"datePublished\":\"2026-03-23T12:20:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/\"},\"wordCount\":378,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NjI2NyM3NDk3MjA0IzIwMTA1Nzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/\",\"name\":\"MIMEDX Announces Launch of CHORIOFIX\u2122 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NjI2NyM3NDk3MjA0IzIwMTA1Nzg=\",\"datePublished\":\"2026-03-23T12:20:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NjI2NyM3NDk3MjA0IzIwMTA1Nzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3NjI2NyM3NDk3MjA0IzIwMTA1Nzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-launch-of-choriofix\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MIMEDX Announces Launch of CHORIOFIX\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MIMEDX Announces Launch of CHORIOFIX\u2122 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/","og_locale":"en_US","og_type":"article","og_title":"MIMEDX Announces Launch of CHORIOFIX\u2122 - Market Newsdesk","og_description":"Further Expands Company\u2019s Broad Portfolio of Advanced Wound Care (\u201cAWC\u201d) Products MARIETTA, Ga., March 23, 2026 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMIMEDX\u201d or the \u201cCompany\u201d) today announced the commercial launch of CHORIOFIX\u2122, the latest advanced wound care innovation in its product portfolio of placental allografts. \u201cCHORIOFIX is an organically developed product, created based on our deep understanding of the scientific and clinical attributes of the chorion layer,\u201d stated Michelle Massee, MIMEDX VP, Research & Development. \u201cIt consists of two chorion layers with an intact intermediate layer, making it our thickest product to date. The allograft\u2019s structure enhances handling, particularly during positioning and suturing, while its uniform, dual-sided chorion configuration eliminates the need for orientation during application.\u201d \u201cI … Continue reading \"MIMEDX Announces Launch of CHORIOFIX\u2122\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-23T12:20:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NjI2NyM3NDk3MjA0IzIwMTA1Nzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MIMEDX Announces Launch of CHORIOFIX\u2122","datePublished":"2026-03-23T12:20:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/"},"wordCount":378,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NjI2NyM3NDk3MjA0IzIwMTA1Nzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/","name":"MIMEDX Announces Launch of CHORIOFIX\u2122 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NjI2NyM3NDk3MjA0IzIwMTA1Nzg=","datePublished":"2026-03-23T12:20:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NjI2NyM3NDk3MjA0IzIwMTA1Nzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3NjI2NyM3NDk3MjA0IzIwMTA1Nzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-launch-of-choriofix\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MIMEDX Announces Launch of CHORIOFIX\u2122"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/946156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=946156"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/946156\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=946156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=946156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=946156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}